New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2013
11:52 EDTZIOP, EXAS, WHX, SPPI, HNZOptions with increasing implied volatility: ZIOP EXAS WHX SPPI HNZ
News For ZIOP;EXAS;WHX;SPPI;HNZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 26, 2014
17:10 EDTSPPISpectrum reports 16.66% stake in CASI Pharmaceuticals
Spectrum entered into the investment agreements in order to acquire shares of common stock of CASI Pharmaceuticals for investment purposes with the goal of increasing the value of the company as a result of, among other things, CASI's development and commercialization of Zevalin and captisol-enabled melphalan in Greater China.
September 24, 2014
07:15 EDTEXASExact Sciences checks show robust early adoption trends, says Jefferies
Jefferies says its analysis of Exact Sciences' enrollment database indicates robust early adoption of Cologuard. The firm has increased conviction in its 2015 test volume forecasts and keeps a Buy rating on the stock with a $20 price target.
September 23, 2014
15:38 EDTEXASExact Sciences volatility elevated
Subscribe for More Information
September 22, 2014
11:48 EDTSPPISpectrum management to meet with Roth Capital
Subscribe for More Information
September 19, 2014
14:56 EDTEXASExact Sciences volatility elevated
Exact Sciences October call option implied volatility is at 88, November is at 78, January is at 71; compared to its 26-week average of 66 according to Track Data, suggesting large near term price movement.
September 18, 2014
07:07 EDTSPPISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information
07:05 EDTSPPISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use